Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.46 USD
Change Today +0.02 / 1.39%
Volume 139.8K
As of 2:11 PM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

mela sciences inc (MELA) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/1/14 - $5.65
52 Week Low
12/31/14 - $1.11
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MELA SCIENCES INC (MELA)

Related News

No related news articles were found.

mela sciences inc (MELA) Related Businessweek News

No Related Businessweek News Found

mela sciences inc (MELA) Details

MELA Sciences, Inc., a medical device company, designs and develops software-driven technology for the early detection of skin cancer to dermatologists in the United States. The company focuses on commercialization of its principal product MelaFind, a non-invasive point-of-care instrument to aid in the detection of melanoma. Its product consists of a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions, which is then analyzed utilizing classification algorithms trained on its proprietary database of melanomas and benign lesions to provide information to assist in the management of the patient’s disease, including information useful in the decision of whether to biopsy the lesion. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.

32 Employees
Last Reported Date: 03/30/15
Founded in 1989

mela sciences inc (MELA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mela sciences inc (MELA) Key Developments

MELA Sciences, Inc. Announces Earnings Results for the Year Ended December 31, 2014

MELA Sciences, Inc. announced earnings results for the year ended December 31, 2014. For the year, the company announced net revenues of $915,000 compared to $536,000 for the same period a year ago. Operating loss was $16,622,000 compared to $24,134,000 for the same period a year ago. Net loss was $14,145,000 compared to $25,948,000 for the same period a year ago. Basic and diluted net loss per common share was $3.03 compared to $6.05 for the same period a year ago. Net cash used in operations was $17,709,000 compared to $19,413,000 for the same period a year ago.

MELA Sciences, Inc. Presents at 8th Annual OneMedForum 2015, Jan-13-2015 02:00 PM

MELA Sciences, Inc. Presents at 8th Annual OneMedForum 2015, Jan-13-2015 02:00 PM. Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States.

MELA Sciences, Inc. Announces Executive Changes

MELA Sciences, Inc. announced that its Board of Directors has named Michael R. Stewart, as the company's next President and Chief Executive Officer, effective December 15. Mr. Stewart, who joined the MELA Sciences Board of Directors in August 2014, will remain a member of the board. Stewart replaces Rose Crane, who has resigned as President and CEO and member of the Board of Directors, effective immediately. Stewart served as president, chief executive officer and board member of NASDAQ-traded Surgical Laser Technologies, Inc. from 1999 until its sale in 2002 to global medical device and skin health company PhotoMedex.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MELA:US $1.46 USD +0.02

MELA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lucid Inc $0.85 USD 0.00
Curis Inc $2.82 USD -0.06
Mauna Kea Technologies €4.59 EUR +0.03
Optiscan Imaging Ltd A$0.06 AUD +0.001
Verisante Technology Inc C$0.10 CAD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MELA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.7x
Price/Book 0.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MELA SCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at